|
Real-time
Euronext Paris
06:16:59 12/10/26 pm AEDT
|
5-day change | 1st Jan Change | ||
| 0.4240 EUR | +3.41% |
|
-17.58% | +205.80% |
| 07/10 | Valerio Therapeutics Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 24/08 | Valerio Therapeutics to Buy Etherna Immunotherapies in EUR30 Million Deal | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +3.41% | -17.58% | -37.01% | +5.50% | +205.80% | +617.69% | +71.54% | -15.52% | -83.71% | 229M | ||
| +0.83% | +3.19% | +5.70% | -0.78% | +9.73% | +41.49% | +94.83% | +404.67% | +1,341.47% | 1,051B | ||
| +1.93% | +2.11% | -1.56% | +1.74% | +26.33% | +37.08% | +67.40% | +63.15% | +122.24% | 630B | ||
| +1.49% | +5.19% | +7.53% | +11.44% | +21.00% | +19.94% | +85.13% | +150.56% | +343.13% | 489B | ||
| +2.26% | +0.90% | +1.16% | +17.86% | +38.32% | +69.32% | +40.73% | +82.16% | +135.10% | 359B | ||
| +0.95% | +3.50% | +3.95% | +6.30% | +9.02% | +23.29% | +40.84% | -1.32% | +49.77% | 344B | ||
| +0.60% | +2.37% | +6.30% | -4.17% | +8.67% | +13.47% | +32.81% | +55.28% | +56.71% | 272B | ||
| +0.46% | +2.30% | -0.99% | -4.57% | -12.73% | -5.42% | +8.22% | +35.27% | +142.69% | 246B | ||
| +1.82% | +2.94% | +9.94% | +14.17% | +26.75% | +42.99% | +46.29% | +100.71% | +152.48% | 224B | ||
| +2.77% | +4.44% | +5.18% | +16.44% | +23.16% | +29.01% | +96.43% | +122.05% | +104.78% | 187B | ||
| +0.85% | +4.34% | -8.17% | -20.62% | -20.83% | -31.07% | -63.74% | -17.95% | +92.60% | 169B | ||
| +1.65% | +1.73% | +2.02% | +17.00% | +13.57% | +14.12% | -14.59% | -32.76% | -14.64% | 161B | ||
| +1.36% | +1.06% | -1.04% | +5.09% | +12.51% | +25.08% | +39.65% | +184.04% | +524.64% | 129B | ||
| -0.77% | -3.32% | -7.10% | +2.67% | +9.60% | +34.49% | +4.36% | +2.96% | +19.31% | 121B | ||
| +0.92% | +4.05% | +6.50% | +16.49% | +14.45% | +22.96% | +105.59% | +365.28% | +473.76% | 109B | ||
| +0.81% | +3.01% | -4.41% | -6.49% | -12.84% | -14.33% | -30.66% | -13.66% | +5.29% | 95.94B | ||
| +0.33% | -0.18% | -5.32% | -10.12% | -3.76% | +7.89% | +15.53% | -0.02% | -17.37% | 92.79B | ||
| +14.21% | +18.41% | +56.28% | +229.57% | +662.97% | +738.61% | +118.96% | -26.25% | - | 89.83B | ||
| +0.94% | +1.54% | -4.47% | +12.34% | -3.28% | +32.22% | -10.71% | +36.66% | +93.38% | 74.55B | ||
| +0.42% | +1.98% | +6.28% | -0.79% | +13.17% | +17.83% | -10.63% | -26.08% | +45.58% | 67.11B | ||
| Average | +1.84% | +1.62% | +2.04% | +15.45% | +52.08% | +86.83% | +36.90% | +73.46% | +188.80% | 245.7B | |
| Weighted average by Cap. | +1.47% | +2.81% | +3.67% | +8.22% | +25.48% | +41.40% | +53.65% | +140.44% | +408.17% |
- Stock Market
- Stocks
- ALVIO Stock
- Sector Valerio Therapeutics
Select your edition
All financial news and data tailored to specific country editions
















